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Abstract
Background: Mammalian Ras genes regulate diverse cellular processes including proliferation and differentiation
and are frequently mutated in human cancers. Tumor development in response to Ras activation varies between
different tissues and the molecular basis for these variations are poorly understood. The murine lens and cornea
have a common embryonic origin and arise from adjacent regions of the surface ectoderm. Activation of the
fibroblast growth factor (FGF) signaling pathway induces the corneal epithelial cells to proliferate and the lens
epithelial cells to exit the cell cycle. The molecular mechanisms that regulate the differential responses of these
two related tissues have not been defined. We have generated transgenic mice that express a constitutively active
version of human H-Ras in their lenses and corneas.
Results: Ras transgenic lenses and corneal epithelial cells showed increased proliferation with concomitant
increases in cyclin D1 and D2 expression. This initial increase in proliferation is sustained in the cornea but not in
the lens epithelial cells. Coincidentally, cdk inhibitors p27Kip1 and p57Kip2 were upregulated in the Ras transgenic
lenses but not in the corneas. Phospho-Erk1 and Erk2 levels were elevated in the lens but not in the cornea and
Spry 1 and Spry 2, negative regulators of Ras-Raf-Erk signaling, were upregulated more in the corneal than in the
lens epithelial cells. Both lens and corneal differentiation programs were sensitive to Ras activation. Ras transgenic
embryos showed a distinctive alteration in the architecture of the lens pit. Ras activation, though sufficient for
upregulation of Prox1, a transcription factor critical for cell cycle exit and initiation of fiber differentiation, is not
sufficient for induction of terminal fiber differentiation. Expression of Keratin 12, a marker of corneal epithelial
differentiation, was reduced in the Ras transgenic corneas.
Conclusions: Collectively, these results suggest that Ras activation a) induces distinct sets of downstream targets in
the lens and cornea resulting in distinct cellular responses and b) is sufficient for initiation but not completion of
lens fiber differentiation.
Background
Ras proteins have been shown to regulate diverse cellu-
lar processes including proliferation, migration, differen-
tiation, apoptosis and senescence [1]. Ras proteins are
small GTP-binding proteins that switch between inactive
guanosine diphosphate (GDP)-bound and active guano-
sine triphosphate (GTP)-bound conformations [2-4].
Active GTP-bound Ras recruits Raf to the cell
membrane. Raf then phosphorylates mitogen-activated
and extracellular-signal regulated kinase kinases (MEKs)
which in turn, phosphorylate extracellular signal-regu-
lated kinases (Erks). Erks activate cytoplasmic substrates
and translocate to the nucleus to stimulate expression of
immediate early genes such as c-jun and E26 transcrip-
tion factors (ETS) [1]. The Ras-Raf-Erk signaling path-
way has been shown to be sufficient for transformation
of murine cell lines [5-7].
Activating somatic missense mutations in Ras genes
(predominantly in codons 12, 13 and 61) have been
found in a number of human cancers [8]. Specific
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associations have been found between the three major
Ras oncogenes, H-, K- and N-Ras, and specific types of
malignancies [1]. For instance, K-Ras mutations are fre-
quent in pancreatic and colon carcinomas, H-Ras muta-
tions in bladder cancers and N-Ras mutations in
melanomas and small intestine malignancies [1]. In
addition, germline mutations in Ras underlie several
developmental disorders including cardio-facio cuta-
neous syndrome (K-Ras), Costello (H-Ras) and Noonan
syndromes (K-Ras) that are characterized by sporadic
tumors and skeletal, cardiac and visual abnormalities
[4]. The reasons for the association of specific Ras genes
with specific tumors or developmental disorders are not
well understood.
Analysis of H-, K- and N-Ras null mice suggests that
Ras proteins perform both unique and overlapping roles
during development. H-Ras and N-Ras single and dou-
ble null mice are viable, fertile and develop normally
[9,10]. Of the two K-Ras isoforms, 4A and 4B, 4B but
not 4A is essential for embryogenesis [11,12]. K-Ras 4B
null embryos die in utero due to anemia, liver and car-
diac defects [11,12]. Replacement of K-Ras coding
sequences with H-Ras results in viable mice [13] sug-
gesting that H-Ras protein can perform the functions of
K-Ras in K-Ras-expressing tissues presumably by acti-
vating the same set of downstream targets. Alterations
in ocular development in K-Ras null mice have not been
reported.
Lens differentiation is initiated when the neuroecto-
derm-derived optic vesicle induces the overlying surface
ectoderm to upregulate the expression of transcription
factors such as Pax6 and Sox2, leading to lens placode
formation [reviewed in [14]]. The lens placode then
invaginates to form a distinctively shaped, symmetrical
lens pit. BMP receptor mediated signaling has recently
been shown to be critical for this placodal invagination
[15]. The lens cells subsequently detach from the overly-
ing ectoderm to form the lens vesicle. Lens detachment
requires the transcription factors FoxE3 and Pitx3
[16-18]. During vesicle closure, the posterior cells of the
lens vesicle initiate fiber cell differentiation, forming the
primary fiber cells. Fiber cells exit from the cell cycle,
undergo dramatic elongation, and express b- and g-crys-
tallins. The anterior cells of the lens remain cuboidal
and retain expression of Pax6 and E-Cadherin [19,20].
The anterior-posterior polarity of the lens is maintained
throughout life by coordination of lens epithelial prolif-
eration, cell cycle exit and initiation of fiber differentia-
tion. Upregulation of the transcription factor Prox1 at
the transition zone near the equator has been shown to
be essential for cell cycle exit [21]. The CDK inhibitors
p27Kip1 and p57Kip2 are upregulated at the transition
zone and are necessary for proper cell cycle exit at the
outset of fiber cell differentiation [22]. An inductive
signal from the neural retina is critical for initiation of
lens fiber differentiation [14,23,24]. Though the identity
of this inductive signal is not known, in vitro and in
vivo studies suggest that this signal is an FGF or FGF-
like molecule [24,25]. Expression of a secreted dominant
negative version of the FGFR3 or targeted deletion of
FGFR1, 2 and 3 in the lens results in the delay or loss
of fiber cell differentiation [26,27]. These results suggest
that FGF receptor mediated signaling is necessary for
initiation of lens fiber differentiation.
After lens vesicle detachment, surface epithelial cells
adjacent to the lens vesicle differentiate to form the cor-
neal epithelium. In mice, corneal epithelial differentia-
tion is marked by Keratin 12 (K12) expression [28]. The
corneal stroma and endothelium are formed by intrao-
cular migration of neural crest and mesodermally-
derived periocular mesenchymal cells [29].
Previous studies showed that activation of the fibro-
blast growth factor (FGF) signaling pathway in the lens
epithelial cells in transgenic mice leads to cell cycle exit
and premature fiber differentiation [30,31]. In contrast,
FGF signaling induces the corneal epithelial cells to first
proliferate and later differentiate into lacrimal or Hard-
erian glands [32,33]. The molecular mechanisms that
regulate proliferative and differentiation responses of the
cornea and lens respectively have not been defined.
Activation of Ras, a downstream effector of FGF sig-
naling, in the lenses of transgenic mice is sufficient to
induce lens epithelial hyperplasia [34]. In addition, H-,
K- and N-Ras genes are expressed ubiquitously within
the eye [34]. However, in previous studies, downstream
targets of Ras activation in the lens were not analyzed.
In addition, the promoter used to drive Ras expression
in the eye was lens-specific thereby precluding analysis
of the effects of Ras activation in the cornea.
In order to test whether activation of Ras in the cor-
nea can phenocopy the effects of FGF signaling, we gen-
erated transgenic mice that express a constitutively
active version of H-Ras (G12V) driven by a modified
Pax6 promoter [19] This promoter is active in the lens,
corneal and conjunctival epithelial cells. Our results sug-
gest that, despite the common embryonic origin of the
lens and the cornea, these two tissues possess distinct
sets of downstream targets that regulate the cellular
responses to Ras activation.
Methods
Generation of Ras transgenic mice
The human H-Ras (G12V) genomic clone, encoding a
constitutively active version of H-Ras (from Dr. Michael
Lieberman, Baylor College of Medicine, Houston), was
digested with SpeI and inserted between the Pax6 pro-
moter/enhancer and the SV40 intron and polyadenyla-
tion sequences [19]. The injection fragment was
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generated by SpeI and StuI digestion and was microin-
jected into individual pronuclei of 1-cell stage FVB/N
mouse embryos. Injected embryos were transferred into
pseudopregnant ICR strain female mice. Animals were
handled following the guidelines provided in US Public
Health Service Policy on Humane Care and Use of
Laboratory Animals. The embryos were allowed to
develop to term and potential Pax6-Ras transgenic mice
were identified by isolating genomic DNA from tail
biopsies and screening by PCR, using primers specific
for the SV40 sequences [26].
Histological Analyses
Embryos were obtained by mating FVB/N females to
heterozygous Ras transgenic males. Pregnant females
were sacrificed at appropriate time points and transgenic
offspring were identified by PCR. Heads of transgenic
mice were removed, fixed in 10% formalin, dehydrated,
embedded in paraffin, sectioned (5-7 μm) and used for
histological analyses, in situ hybridization and
immunohistochemistry.
In situ hybridization
To analyze patterns of gene expression, [35S] UTP-
labeled riboprobes were generated. The SV40 antisense
riboprobe was synthesized using EcoRI-digested SV40
DNA and T3 RNA polymerase (Promega). The FoxE3
antisense probe was synthesized using HindIII-digested
mouse FoxE3 cDNA and T3 RNA polymerase. The
Pitx3 antisense probe was synthesized using XhoI-
digested mouse Pitx3 cDNA and SP6 RNA polymerase.
The Prox1 antisense probe was synthesized using SmaI-
digested mouse Prox1 cDNA and T3 RNA polymerase.
The p57Kip2 antisense probe was synthesized using
BamHI-digested mouse p57Kip2 cDNA and T3 RNA
polymerase. The Erm, Pea3, Spry1 and Spry4 antisense
probes were synthesized using EcoRI-digested Erm,
Pea3, Spry1 and Spry4 cDNAs and T7 RNA polymerase.
The Spry2 antisense probe was synthesized using SacI-
digested mouse Spry2 cDNA and T3 RNA polymerase.
The cyclin D1 antisense probe was synthesized using
XhoI-digested mouse cyclin D1 cDNA and T3 RNA
polymerase. The cyclin D2 antisense probe was synthe-
sized using SphI-digested mouse cyclin D2 cDNA and
T7 RNA polymerase. The cyclin B1 antisense probe was
synthesized using HincII-digested mouse cyclin B1
cDNA and T7 RNA polymerase. The p21Cip1 antisense
probe was synthesized using ApaI-digested mouse
p21Cip1 cDNA and T7 RNA polymerase. The Hes1 anti-
sense probe was synthesized using HindIII-digested
mouse Hes1 cDNA and T7 RNA polymerase. In situ
hybridizations were performed using the same hybridi-
zation and washing conditions as described previously
[32]. The hybridized slides were soaked in Kodak NTB-
2 emulsion, dried and exposed for 4-10 days at 4°C. Fol-
lowing development and fixation, the slides were
counterstained with hematoxylin. Bright and dark-field
images were captured separately using a Nikon Eclipse
E600 microscope. Silver grains in the dark field images
were pseudo-colored red using ADOBE Photoshop CS
and overlaid on corresponding bright field images.
Immunohistochemistry
Immunohistochemistry on paraffin-embedded tissue sec-
tions was performed as follows. Slides containing ocular
sections were first deparaffinized and rehydrated. Anti-
gens were retrieved by microwave treatment in 10 mM
Sodium Citrate buffer (pH 6.0). Following antigen retrie-
val, the tissue sections were blocked with 10% normal
horse serum for 30 minutes, at room temperature. The
slides were then incubated with anti-Pax6 (catalog num-
ber PRB-278P, 1:250; Covance, Berkeley, CA), anti-E-
Cadherin (catalog number 610181, 1:1000; BD Trans-
duction Laboratories, San Jose, CA), anti-Keratin 14
(Krt14) (catalog number PRB-155P, 1:2000; Covance),
anti-Prox1 (catalog number ab5475, 1:1000; Chemicon,
Temecula, CA), anti-a A crystallin (catalog number
ab5595, 1:10,000; Abcam, Cambridge, MA), anti-b crys-
tallin (catalog number sc-22745, 1:400; Santa Cruz Bio-
technology, Santa Cruz, CA), anti-Keratin 12 (Krt12)
(catalog number KAL-KR074, 1:200; Cosmo Bio Com-
pany, Tokyo, Japan), anti-phospho Erk1/2 (catalog num-
ber 4370, 1:50; Cell Signaling Technology, Danvers,
MA), anti-p57Kip2 (catalog number ab4058, 1:250;
Abcam), anti-14-3-3s (catalog number sc-7683, 1:100;
Santa Cruz Biotechnology), anti-Ki67 (catalog number
M7249, 1:200, Dako Cytomation, Carpinteria, CA) or
anti-Trp63 (4A4) (catalog number sc-8431, 1:100; Santa
Cruz) antibody overnight at 4°C. Following brief washes
in PBS, the slides were incubated with the appropriate
biotinylated-secondary antibodies; anti-rabbit IgG (cata-
log number BA-1000, 1:200; Vector Labs, Burlingame,
CA) for Pax6, Prox1, a A-crystallin, b-crystallin, phos-
pho-Erk1/2, p57Kip2, Krt12 or Krt14, anti-mouse IgG
(catalog number BA-2000, 1:200; Vector Labs) for E-
Cadherin or Trp63, anti-goat IgG (catalog number BA-
5000, 1:200; Vector Labs) for 14-3-3s and anti-rat IgG
(catalog number BA-4000, 1:200, Vector Labs) for Ki67
for 30 minutes at 37°C. Antigen-antibody complexes
were then detected using streptavidin-linked Alexa 594
(Invitrogen, Carlsbad, CA) at 1:1000 dilution. Sections
were mounted using ProLong Antifade media containing
DAPI (Invitrogen, Carlsbad, CA). Images were captured
using a Nikon Eclipse E600 microscope.
Proliferation assay
DNA replication was examined by BrdU incorporation
as described previously [26]. Cell proliferation was ana-
lyzed by counting the number of BrdU positive nuclei.
Quantification of cell proliferation (BrdU labeling index)
was performed by determining the fraction of BrdU
labeled nuclei over the total number of nuclei present
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on a given section. Cells in the interior of the Pax6-Ras
transgenic lenses that expressed markers such as FoxE3
and Prox1 were counted as lens cells. A minimum of 3
different embryos were analyzed per genotype/time
point. The number of sections used for quantification is
indicated in the graphs (Fig. 4I). Analysis was performed
by two-tailed Student’s t-test at P ≤ 0.05.
Results
In order to test whether activation of Ras, a downstream
effector of FGF signaling, can mimic the effects of FGF
stimulation on the lens and cornea in the murine eye,
we generated transgenic mice with targeted expression
of a constitutively active (and oncogenic) version of
human H-Ras under the control of the Pax6 promoter
(Fig. 1). This promoter is active from embryonic day 9.5
(E9.5) in the lens, corneal and conjunctival epithelial
precursors [19]. The Pax6-Ras transgene was con-
structed by inserting the human H-Ras gene (G12V)
between the Pax6 enhancer/promoter and SV40 intron
and polyadenylation site. The transgene was microin-
jected and two founders were generated. Stable trans-
genic lines (OVE2043, OVE2044) were established from
these founders. Transgenic line OVE2043 did not show
any ocular abnormalities. OVE2044 mice showed micro-
phthalmia and were born with open eyelids.
Transgene expression
Transgene expression in the two Pax6-Ras transgenic
lines was examined by in situ hybridizations (Fig. 2). No
transgene expression was seen in the OVE2043 line
(data not shown). In the OVE2044 line, at E11.5 and
E13.5, transgene expression could be seen in the lens,
corneal and conjunctival epithelial cells (Fig. 2B, D).
Low levels of Ras transgene expression were seen in a
subset of neuroblasts in the retina at E13.5 (Fig. 2D)
with stronger expression at E16.5 (Fig. 2F). As transgene
expression was seen only in the OVE2044 transgenic
line, further studies were performed on this line and the
results are presented here. In this manuscript we study
the initial changes in lens and corneal differentiation.
Later changes in retinal organization are not evaluated
in this report.
Ras transgenic mice show altered lens and corneal
development
In order to assess the alterations in ocular development
and morphology, sections of Pax6-Ras transgenic mice
were stained with hematoxylin and eosin (Fig. 3). Non-
transgenic littermates were used as controls. At E10.5,
the lens placode had invaginated to form the lens pit
(Fig. 3A, A’). In the Ras transgenic embryos, morpholo-
gical changes at the anterior margin of the lens pit were
visible (Fig. 3B, B’). The boundary between the surface
and lens pit epithelial cells was well defined in the non-
transgenic embryos (Fig. 3A, A’). In contrast, in the
transgenic embryos, extra cells extending into the inter-
ior of the lens pit were seen (Fig. 3B, B’, arrow). At
E11.5, Ras transgenic lenses and corneas displayed
epithelial hyperplasia (Fig. 3D, D’). In addition, the extra
cells seen in the lens pit were internalized within the
lumen of the developing lens. (Fig. 3D, D’, arrow). By
E13.5, Ras transgenic lenses had become embedded in
the cornea (Fig. 3F, F’). At E16.5, the eyelids had failed
to close in the Ras transgenic embryos (Fig. 3H). In
addition, lenses remained attached to the cornea and
the lens epithelial cells showed an elongated morphol-
ogy (Fig. 3H’, bracket) in contrast to the cuboidal mor-
phology in the lens epithelial cells of nontransgenic
embryos (Fig. 3G’, bracket). The corneal stroma was dis-
organized and a distinctive corneal endothelium was not
seen (Fig. 3H’). At E18.5, vacuoles were present inside
the defective lens (Fig. 3J, arrows) and the central cor-
nea showed epithelial and stromal defects (Fig. 3J, J’).
Increased apoptosis in Ras transgenic lenses
In order to assess apoptosis in Ras transgenic lens and
corneal epithelial cells, we examined cleavage of cas-
pase-3, a critical mediator of apoptosis, by immunohis-
tochemistry (Fig. 3K, L). Activated caspase 3 was
detected in the transgenic epithelial cells within the lens
that were not in contact with the basement membrane
(Fig. 3L, arrows). Positive staining was not seen in the
lens epithelial cells that expressed the Ras transgene but
retained contact with the basement membrane. Simi-
larly, activated caspase 3 staining, for the most part, was
not seen in the Ras transgenic corneas (Fig. 3L).
Figure 1 Schematic diagram of the Pax6-Ras transgene. A human H-Ras (G12V) genomic clone (~3.1 Kb) was inserted between a modified
Pax6 promoter/enhancer (2.3 Kb) and an intron and polyadenylation (polyA) sequence derived from the SV40 virus (850 bp). The lens/cornea
enhancer is contained between the BglII/AccI sites (clear box). The SV40 polyA sequences were used to make riboprobes for detection of
transgene expression.
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Increase in proliferation of Ras transgenic lens and
corneal epithelial cells
In order to assess cell proliferation in the Ras transgenic
embryos, BrdU incorporation assays and Ki67 immuno-
histochemistry were performed (Fig. 4). The BrdU incor-
poration assay allows the identification of cells in S
phase of the cell cycle. Ki67 is expressed by cycling cells
in G1, S, G2 and M phase but not G0 cells. Ras trans-
genic lenticular and corneal epithelial cells show a sig-
nificant increase in BrdU labeling at E11.5 (Fig. 4B, I).
The cells in the interior part of the lens vesicle that
were not in contact with the basement membrane also
incorporated BrdU (Fig. 4B, arrow). At E13.5, a signifi-
cant increase in the BrdU labeling index of corneal, but
not lens, epithelial cells was seen (Fig. 4D, I). Both BrdU
(Fig. 4A-D) and Ki67 (Fig. 4E-H) assays showed consis-
tent results. Thus, Ras transgenic lenticular and corneal
epithelial cells show a significant increase in prolifera-
tion initially but later, this increase is sustained in the
corneal but not in the lens epithelial cells. Alterations in
Figure 2 Transgene expression. In situ hybridizations were performed on ocular sections of nontransgenic (A, C, E) and Pax6-Ras transgenic (B,
D, F) embryos using an 35S-labeled SV40 riboprobe. Dark-field images were overlaid on respective bright-field images and silver grains were
pseudocolored red. Ras transgene expression was seen in the lens, cornea and conjunctival epithelial cells at E11.5 and E13.5 (B, D) and in some
retinal neuroblasts at E13.5 and E16.5 (D, F). Discontinuity in the corneal epithelium in panel B (asterisk) is due to a sectioning artifact.
Abbreviations; C, corneal epithelium; Cj, conjunctival epithelium; le, lens epithelium; lf, lens fibers; nr, neural retina. The scale bar (E) represents
100 μm in panels A-D and 250 μm in panels E, F.
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conjunctival epithelial proliferation will be described
elsewhere (DB, ES, RW, VG).
Altered lens differentiation in Ras transgenic mice
Alterations in the lens differentiation program were
assessed by in situ hybridization and immunohisto-
chemistry (Fig. 5). Pax6, FoxE3, Prox1 and Pitx3 are
transcription factors that are critical for lens specifica-
tion (Pax6), lens vesicle detachment (FoxE3, Pitx3) and
cell cycle exit of lens epithelial cells (Prox1)
[16-18,21,35-37]. In nontransgenic lenses, Pax6, E-Cad-
herin and FoxE3 are expressed in the epithelial cells
(Fig. 5A, C, E), b-crystallin in differentiated fiber cells
(Fig. 5O, Q) and Prox1 and a-crystallin in both epithe-
lial and fiber cells (Fig. 5G, I, M). Expression of Pax6
(Fig. 5B), FoxE3 (Fig. 5F) and Pitx3 (Fig. 5L) in the
transgenic lens epithelial cells was similar to
Figure 3 Pax6-Ras transgenic mice show altered lens and corneal development. Heads of E10.5 (A-B’), E11.5 (C-D’), E13.5 (E-F’), E16.5 (G-H’)
and E18.5 (I-J’) nontransgenic (NT) and Pax6-Ras transgenic mice were sectioned and stained with hematoxylin and eosin. Panels A-J’ are higher
magnifications of boxed regions in A-J respectively. Asterisks in panels D, D’ indicate sectioning artifacts. Arrows in B, B’, D and D’, point to
abnormal clusters of cells in the interior of the lens. Arrow in G’ points to the corneal endothelium. Arrows in J point to the vacuoles within the
lens. Lens epithelial hyperplasia was seen in the Ras transgenic embryos (arrow in F’) and Ras transgenic lenses failed to detach from the surface
ectoderm (D, D’). Eyelids failed to close in Ras transgenic embryos (H) and the corneal stromal cells were disorganized (F, H, J). K, L. Activated
caspase 3 was detected by immunohistochemistry (L, arrows). Antigen-antibody complexes are in red and the nuclei are stained blue with DAPI.
Abbreviations; C, corneal epithelium; Cj, conjunctival epithelium; eyl, eyelid; le, lens epithelium; lf, lens fibers; lp, lens pit; nr, neural retina. The
scale bar (E’) represents 50 μm in panels A, B, C, D, K, L, 100 μm in panels E, F, 25 μm in A’-H’ and 250 μm in panels G-J.
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nontransgenic lenses (Fig. 5A, E, K). E-Cadherin expres-
sion in the transgenic lens epithelial cells was compar-
able, although perhaps not identical, to nontransgenic
lenses (Fig. 5D, T). Prox1 expression is normally upre-
gulated near the equator of the lens where the fiber dif-
ferentiation is initiated (Fig. 5G, I, white arrows). In
contrast, Prox1 was upregulated in the Ras transgenic
lens epithelial cells (Fig. 5H, J, arrowheads) but expres-
sion in the fiber cells was similar to wild type controls
(Fig. 5H, J). Expression of a-crystallin in the transgenic
lens epithelial cells (Fig. 5N) and b-crystallins in the
transgenic lens fiber cells were similar to nontransgenic
controls (Fig. 5O-R). The extra cells in the interior part
of the Ras transgenic lenses that were not in contact
with the basement membrane expressed lens epithelial
markers including FoxE3 (Fig. 5F), Pitx3 (Fig. 5L) and
a-crystallin (Fig. 5N). In addition, in a subset of these
cells, expression of Prox1 (Fig. 5H, J) and b-crystallin
(Fig. 5P, R, arrows) could be detected. Double labeling
with b-crystallin and E-Cadherin antibodies suggested
co-localization of these two proteins in some of the
abnormal epithelial cells (Fig. 5S, T). These results show
that some markers of lens fiber differentiation are
induced in the anterior cells of the transgenic lenses.
Figure 4 Cell proliferation in Ras transgenic mice. BrdU (A-D) and Ki67 (E-H) immunohistochemistry was performed on nontransgenic (NT) (A,
C, E, G) and Pax6-Ras transgenic (B, D, F, H) embryos of age E11.5 (A, B, E, F) and E13.5 (C, D, G, H). Antigen antibody complexes are in red and
nuclei are stained blue with DAPI. Quantification of the BrdU proliferation index is shown in panel I. Ras transgenic lens epithelial cells showed a
significant increase in BrdU incorporation at E11.5 (I) but not at E13.5 (I). The number of sections counted for each genotype and time point are
indicated in the graph. Error bars indicate standard deviation. Asterisk in the graph indicates a significance of P < 0.05. The scale bar (G)
represents 50 μm in panels A, B, E-H and 100 μm in panels C, D.
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Erk activation in Ras transgenic lenses and corneas
Erk activation in the Ras transgenic lenses and corneas
was assessed by immunohistochemistry using an anti-
phospho Erk1/2 antibody (Fig. 6). Erk1 and 2 are phos-
phorylated in response to Ras activation [38,39]. Phos-
pho-Erk1/2 immunoreactivity could be detected in the
lens fiber cells of E11.5 and E13.5 nontransgenic
embryos (Fig. 6A, C). Elevated levels of phospho-Erk1/2
were detected in the Ras transgenic lens but not in the
corneal epithelial cells (Fig. 6B, D). In addition, a modest
reduction of phospho-Erk1/2 levels was seen in the Ras
transgenic lens fiber cells at E13.5 (Fig. 6D, lf). These
results show that the lens and the corneal epithelial cells
show differential Erk1/2 phosphorylation in response to
Ras activation.
Ras targets in the lens and cornea
In order to test whether Ras activation can induce
expression of ETS transcription factors (Erm and Pea3)
or negative feedback regulators of Ras-Raf-Erk signaling
(Spry1, 2 and 4), in the lens and corneas, in situ hybridi-
zations were performed on E13.5 ocular sections of Ras
transgenic embryos (Fig. 7). Erm, Pea3, Spry1 and 2
Figure 5 Altered lens differentiation in Ras transgenic embryos. Immunohistochemistry (A-D, I, J, M-T) and in situ hybridizations (E-H, K, L)
were performed on nontransgenic (NT) and Pax6-Ras transgenic embryos to detect expression of Pax6 (A, B), E-Cadherin (C, D, S, T), FoxE3 (E, F),
Prox1 (G-J), Pitx3 (K, L), a-crystallin (M, N) and b-crystallin (O-T). In panels A-D, I, J and M-R, antigen antibody complexes are in red and in panels
S and T, green and red. In all these panels nuclei are stained blue with DAPI. In situ hybridizations were performed using 35S-labeled riboprobes
(E-H, K, L). Dark-field images were overlaid on respective bright-field images and silver grains were pseudocolored red. Upregulation of Prox1 (H,
J) expression in a subset of Ras transgenic lens epithelial cells suggests initiation of early fiber differentiation. Co-localization of b-crystallin and E-
Cadherin was seen in some of the Ras transgenic lens cells (T, arrows). The staining in the vitreous (panel C, asterisk) is due to anti-mouse
secondary antibody binding to IgGs in the blood vessels. White arrows in panel G, H and I point to the lens equatorial region where fiber
differentiation is initiated. Green arrowheads point to lens epithelial cells (G-J). Abbreviations; C, corneal epithelium; Cj, conjunctival epithelium; le,
lens epithelium; lf, lens fibers; nr, neural retina. The scale bar (I) represents 100 μm in panels A-D, 25 μm in panels I, J, S, T and 50 μm in panels
E-H, K-R.
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were upregulated in the Ras transgenic corneal and con-
junctival epithelial cells (Fig. 7B, D, F, H) in contrast to
nontransgenic corneas (Fig. 7A, C, E, G). Significant
upregulation of Erm, but not Pea3, Spry1 or 2, expres-
sion was seen in the Ras transgenic lens epithelial cells
(Fig. 7B, D, F, H). Spry 4 was not induced in the trans-
genic lens or cornea (Fig. 7J). Expression of Erm, Spry1
and 2 in the Ras transgenic lens fiber cells was similar
to nontransgenic controls (Fig. 7B, F, H). In summary,
different sets of downstream targets were activated in
the Ras transgenic lens and corneal epithelial cells.
Cell cycle targets of Ras in the lens and cornea
Expression of genes that regulate the cell cycle was ana-
lyzed by in situ hybridization and immunohistochemis-
try (Fig. 8). D-type cyclins are often activated in
response to growth factor and/or Ras stimulation and
can promote entry into S phase [40]. p27Kip1 and
p57Kip2 have been shown to regulate cell cycle exit dur-
ing fiber cell induction [22]. Upregulation of cyclins D1
and D2 was seen in the Ras lens and corneal epithelial
cells (Fig. 8B, D). Cyclin B1 was upregulated in the
transgenic corneal epithelial cells (Fig. 8F) but
expression in the lenses was similar to nontransgenic
controls (Fig. 8E). No alterations in cyclin E expression
were seen in Ras transgenic lenses and corneas (data
not shown). p21Cip1 expression was upregulated in both
the lens and corneal epithelial cells (Fig. 8H). Expression
of p57Kip2 is normally upregulated near the equator
where the lens epithelial cells exit the cell cycle and
initiate fiber differentiation (Fig. 8I, K, white arrows).
p57Kip2 mRNA and p57Kip2 protein levels were upregu-
lated in Ras transgenic lens epithelial cells (Fig. 8J, L,
arrowheads). Similarly, p27Kip1 mRNA levels were ele-
vated in the transgenic lens but not corneal epithelial
cells (Fig. 8M, N). In summary, D-type cyclins were ele-
vated in both the lens and corneal epithelial cells but B-
type cyclins were elevated only in the corneal epithelial
cells. CDK inhibitors p27Kip1 and p57Kip2 were preferen-
tially upregulated in the lens but not in the corneal
epithelial cells. In contrast, p21Cip1 was upregulated in
both epithelial cell types.
Altered corneal differentiation in Ras transgenic mice
Alterations in corneal differentiation in the Ras trans-
genic corneas were assessed by in situ hybridization and
Figure 6 Erk1/2 phosphorylation in Ras transgenic eyes. Immunohistochemistry was performed on E11.5 (A, B) and E13.5 (C, D) Ras
transgenic (B, D) and nontransgenic (NT) (A, C) embryos using an anti-phospho-Erk1/2 antibody. Antigen antibody complexes are in red and
nuclei are stained blue with DAPI. Elevated phospho-Erk1/2 levels were detected in the Ras transgenic lens epithelial cells (Compare C and D,
green arrowheads). White arrows in C and D point to the lens equatorial region where fiber differentiation is initiated. Abbreviations; C, corneal
epithelium; le, lens epithelium; lf, lens fibers; nr, neural retina. The scale bar (C) represents 50 μm in panels A-D.
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Figure 7 Ras targets in the lens and cornea. In situ hybridizations were performed on ocular sections of nontransgenic (NT) (A, C, E, G, I) and
Pax6-Ras transgenic (B, D, F, H, J) E13.5 embryos using 35S-labelled Erm, Pea3, Spry1, 2 and 4 riboprobes. Dark-field images were overlaid on
respective bright-field images and silver grains were colored red. Erm (B) expression was upregulated in the Ras transgenic lens and cornea. Pea3
(D), Spry1 (F) and Spry2 (H) expression was upregulated in the Ras transgenic corneas. Abbreviations; C, corneal epithelium; Cj, conjunctival
epithelium; le, lens epithelium; lf, lens fibers; nr, neural retina. The scale bar (I) represents 100 μm in panels A-J.
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immunohistochemistry (Fig. 9). Hes1, a transcription
factor and a downstream target of the Notch signaling
pathway, is modestly expressed in the corneal epithelial
cells (Fig. 9A) and has been shown to be critical for
maintenance of the corneal progenitor/stem cells [41].
Keratin 12 (Krt12) expression is restricted to the corneal
epithelial cells within the eye (Fig. 9C) and has been
shown to be essential for corneal differentiation [42].
Krt14, 14-3-3s and Trp63 are expressed in the corneal,
conjunctival and skin epithelia (Fig. 9E, G, I). At E13.5,
Hes1 expression was expanded in the Ras transgenic
corneas but was unaltered in the Ras transgenic lenses
(Fig. 9A, B). At E16.5, Krt12 expression was significantly
reduced in the Ras transgenic corneas (Fig. 9D) but
Krt14, 14-3-3s and Trp63 were still expressed (Fig. 9F,
H, J). Reduction in Krt12 expression indicates that term-
inal differentiation of corneal epithelial cells is inhibited
by expression of activated Ras.
Discussion
The Pax6-Ras transgenic mice were generated in order
to test whether Ras activation in the corneal and lens
epithelial cells can phenocopy the effects of FGF stimu-
lation. Similar studies performed on embryonic retinal
pigmented epithelial (RPE) cells in transgenic mice sug-
gest that Ras activation can mimic the effects of FGF
Figure 8 Cell cycle targets in the lens and cornea. In situ hybridizations (A-J, M, N) and immunohistochemistry (K, L) were performed on
nontransgenic (NT) and Pax6-Ras transgenic E13.5 embryos to detect expression of cyclin D1 (Ccnd1) (A, B), cyclin D2 (Ccnd2) (C, D), cyclin B1
(CcnB1) (E, F) and cdk inhibitors p21Cip1 (G, H), p57Kip2 (I-L) and p27Kip1 (M, N). For in situ hybridizations (A-J, M, N), dark-field images were overlaid
on respective bright-field images and silver grains were colored red. For immunohistochemistry (K, L), antigen antibody complexes are in red
and nuclei are stained blue with DAPI. Discontinuities in the corneal epithelium (B, C, D, F, G, H, I, asterisks) are sectioning artifacts. Cyclins D1 (B),
D2 (D) and B1 (F) were upregulated in the Ras transgenic corneas. p57Kip2 (J, L) and p27Kip1 (N) were upregulated in the Ras transgenic lens
epithelial cells but not corneas. p21Cip1 was upregulated in the Ras transgenic lenses and corneas. Abbreviations; C, corneal epithelium; Cj,
conjunctival epithelium; le, lens epithelium; lf, lens fibers; nr, neural retina. The scale bar (G) represents 100 μm in panels A-J, M, N and 50 μm in
panels K, L.
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Figure 9 Corneal differentiation in Ras transgenic mice. In situ hybridizations (A, B) and immunohistochemistry (C-J) were performed on
nontransgenic (NT) and Pax6-Ras transgenic embryos to detect expression of Hes1 (A, B), Keratin 12 (Krt12) (C, D), Keratin 14 (Krt14) (E, F), 14-3-
3s (G, H) and Trp63 (I, J). For in situ hybridizations (A, B), dark-field images were overlaid on respective bright-field images and silver grains were
colored red. For immunohistochemistry (C-J), antigen antibody complexes are in red and nuclei are stained blue with DAPI. Ras transgenic
corneal epithelial cells show an expansion of the Hes1 expression domain (B) and reduced Krt12 expression (D). Abbreviations; C, corneal
epithelium; Cj, conjunctival epithelium; le, lens epithelium; lf, lens fibers; nr, neural retina. The scale bar (I) represents 100 μm in panels A-F, I, J
and 50 μm in panels G, H.
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stimulation and is sufficient to induce the RPE cells to
initiate a neuronal program of differentiation [43]. Lens-
specific expression of FGF10 in transgenic mice stimu-
lates corneal epithelial cells to first proliferate and later
differentiate into lacrimal and Harderian glands. Our
results suggest that Ras activation is sufficient to induce
proliferation but not glandular differentiation of corneal
epithelial cells. Ras transgenic lenticular and corneal
epithelial cells show increased proliferation with conco-
mitant increases in cyclin D1 and D2 expression. The
cell cycle inhibitor p21Cip1 was upregulated in both the
lens and corneal epithelia. The initial increase in lens
epithelial proliferation was not sustained perhaps due to
the upregulation of p27kip1 and p57kip2. Phospho-Erk1
and Erk2 levels are elevated in the lens but not in the
cornea. Consistent with this result, expression of Sprys1
and 2, downstream targets of FGF signaling and negative
feedback regulators of Ras-Raf-Erk pathway, was higher
in the Ras transgenic corneal than in the lens epithelial
cells. Pea3, an ETS transcription factor, was elevated in
the corneal but not in the lens epithelial cells. In con-
trast, transcription of Erm, another ETS transcription
factor, was elevated in both the lens and corneal epithe-
lial cells. Both lens and corneal differentiation programs
were sensitive to Ras activation. Ras transgenic lenses
showed defects in morphogenesis at the lens pit stage.
Transgenic lens epithelial cells showed upregulation of
Prox1, a transcription factor critical for cell cycle exit
and initiation of fiber differentiation. Keratin 12, a mar-
ker of corneal epithelial differentiation, was significantly
reduced in the Ras transgenic corneas. Collectively,
these results show that a) lens and corneal epithelial
growth and differentiation are sensitive to alterations in
Ras activity and b) Ras activation can induce distinct
sets of downstream targets in the lens and cornea.
In our transgenic model, the H-Ras protein is consti-
tutively active and not subject to feedback regulation. It
is therefore, possible (and perhaps likely) that Ras activ-
ity is significantly higher than normal. Upregulation of
p21Cip1 (a gene that is not upregulated during normal
development) in the Ras transgenic lenses and corneas
would be consistent with this possibility. Nonetheless,
our results show that constitutive Ras signaling is not
sufficient to induce glandular differentiation in the cor-
nea. As early molecular markers of lacrimal or Harder-
ian gland differentiation are not currently known,
initiation of glandular differentiation in the Ras corneal
epithelial cells could not be analyzed. Our results imply
that other signaling pathways downstream of FGF recep-
tor stimulation are necessary for ocular gland differen-
tiation. Ras activation, however, is sufficient to induce
an increase in corneal epithelial proliferation. Similarly,
lens epithelial cells also respond to Ras activation by
hyperproliferaton. Ras activation in the lens and corneal
epithelial cells induces transcriptional upregulation of
cyclins D1 and D2. As cyclin E was not induced in these
tissues, it is likely that Ras-induced entry into S phase
(assayed by BrdU incorporation) is due to the upregula-
tion of cyclins D1 and D2.
Cdk inhibitors, p27Kip1 and p57Kip2, are normally
upregulated in the transition zone of the lens where the
fiber differentiation program is initiated. Both p27Kip1
and p57Kip2 cooperatively regulate cell cycle exit at the
onset of fiber cell differentiation [22]. Ras activation in
the lenticular, but not the corneal, epithelial cells upre-
gulated both p27Kip1 and p57Kip2. In addition, the initial
increase in proliferation seen at E11.5 in the lens epithe-
lial cells was not sustained at E13.5 in contrast to cor-
neal epithelial cells of the same age. These results taken
together suggest that the deceleration in lens epithelial
proliferation at E13.5 could be due to induction of Cdk
inhibitors p27Kip1 and p57Kip2 in the lens. The reasons
for specific upregulation of these genes in the lens but
not in the cornea are not clear. However, expression of
the transcription factor, Prox1, offers us a clue. The
transcription factor Prox1 has been shown to be neces-
sary for transcriptional upregulation of p27Kip1 and
p57Kip2 in the lens as expression of these two genes is
not seen in Prox1 null lenses [21]. In lymphatic vascular
endothelial cells Prox1 expression is sufficient to activate
p57Kip2 expression and to promote cell cycle exit [44].
These studies considered together would suggest that
transcriptional upregulation of p27Kip1 and p57Kip2 in
Ras transgenic lenses could be due to Ras-induced upre-
gulation of Prox1. It is not clear why Ras-induced upre-
gulation of Prox1 is specific to the lens but not the
cornea.
Ras transgenic lenses also showed increased apoptosis.
Apoptosis, however, was not seen in all the lens cells
that expressed the Ras transgene suggesting that apopto-
sis was not a non-specific consequence of Ras transgene
expression. Apoptosis in the lens was seen only in the
abnormal cells in the interior of the lens. These results
are interesting as oncogenic Ras has been shown to
block suspension induced apoptosis or anoikis in vitro
[45]. Ras is able to protect cells from anoikis through
the activation of Akt via PI3 kinase [45]. Whether the
PI3 kinase-Akt pathway is inactive in the Ras transgenic
lenses remain to be verified.
In the Ras transgenic mice, early events during lens
differentiation including lens placode formation and lens
invagination were not affected. However, Ras transgenic
lenses failed to form a normal lens pit resulting in archi-
tectural changes at the lens pit stage. We considered the
possibility that the altered lens pit architecture is caused
by loss of FoxE3 or Pitx3 expression as FoxE3 and Pitx3
mutants show persistence of a lens stalk [16-18]. How-
ever, expression of both Foxe3 and Pitx3 were unaltered
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in Ras transgenic lenses. We also analyzed the expres-
sion of E-Cadherin, a cell adhesion protein that plays a
role in lens invagination [46]. E-Cadherin was still
expressed in the Ras transgenic lenses. It seems likely
that the alterations in the architecture of the lens pit are
a consequence of altered proliferation of cells in or
around the lens placode in response to Ras stimulation.
If this is true, it suggests that cell proliferation and inva-
gination have to be precisely coordinated during lens
invagination.
Previous studies have shown that activation of the
FGF signaling pathway in the lens epithelial cells in vivo
is sufficient for induction of fiber differentiation [30,31].
In vitro experiments using rat lens epithelial explants
have shown that FGFs at low concentration, can induce
proliferation and at high concentration, can induce cell
cycle exit and differentiation [47]. Our results suggest
that Ras activation in the lens epithelial cells induces a
modest increase in cell proliferation, at least transiently.
Concurrently, there is upregulation of expression of
some of the early markers of lens differentiation such as
Prox1, p27Kip1 and p57Kip2. However, b-crystallin, a mar-
ker of terminal differentiation of lens fibers, was
detected in only a small fraction of the Ras transgenic
lens epithelial cells. Some of these cells also expressed
lens epithelial markers including Pax6 and E-Cadherin,
suggesting an abnormal or ambiguous state of differen-
tiation. These results suggest that Ras activation is suffi-
cient to initiate only limited aspects of the lens fiber
differentiation program. These results are consistent
with previous reports that show Erk signaling, while
necessary for FGF-induced lens fiber elongation, is not
sufficient for b-crystallin expression [48,49].
Both corneal and lens epithelial cells originate from
the surface ectoderm. Interestingly, our results suggest
that, in spite of their common embryonic origin, the
lens and the cornea activate distinctive sets of down-
stream targets in response to Ras activation. Phospho-
Erk levels were elevated in the Ras transgenic lens but
not in the cornea. In addition, negative feedback regula-
tors of Raf-Erk signaling such as Spry1 and Spry2 are
elevated more in the cornea than in the lens epithelial
cells. These observations provide correlative evidence
that Spry1 and 2 may be inhibiting Raf-Erk signaling in
the corneal epithelial cells. Alternatively, it is possible
that signaling effectors downstream of Ras that are criti-
cal for Erk phosphorylation are expressed in the lens
more than in the cornea. This model would predict that
Ras-induced expression of downstream targets in the
cornea is independent of Erk activation and that Ras sig-
nals through other effectors. Transcription factors that
show tissue-specific expression such as Trp63 in the
cornea or Prox1 in the lens may also dictate the
response of these tissues to Ras signaling. Nonetheless,
the differential activation of downstream targets in these
two related tissues is a novel discovery that warrants
further analysis.
Our results suggest that corneal differentiation is sen-
sitive to changes in Ras activity. Interestingly, in contrast
to the lens, Ras stimulation inhibits corneal epithelial
differentiation. Expression of Krt12, a marker of corneal
epithelial differentiation, is significantly reduced. Expan-
sion of the expression domain of Hes1, a gene critical
for maintenance of pleuripotency [41], is consistent with
the block in differentiation. Expression of other proteins
such as 14-3-3s, Krt14 and Trp63 that are normally
expressed in, but not restricted to, the corneal epithe-
lium was maintained. Therefore, it is likely that the inhi-
bition of Krt12 expression in the Ras transgenic corneas
is a specific effect of Ras stimulation.
Conclusions
Collectively, our results suggest that Ras activation
induces distinct sets of downstream targets in the lens
and cornea resulting in distinct cellular responses.
These results support the model that responses to Ras
signaling are tissue specific and dictated by the autono-
mous programming of the responding tissues. These
results also suggest the possibility that the associations
seen between mutations in specific Ras genes and speci-
fic types of malignancies could be explained at least in
part, by cell-specific activation of different signaling
effectors and downstream targets.
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